Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model. - Li, Xuehua; Zhong, Yingkui; Yuan, Chenglang; Lin, Jinjiang; Shen, Xiaodi; Guo, Minyi; Lu, Baolan; Meng, Jixin; Wang, Yangdi; Zhang, Naiwen; Luo, Zixin; Hu, Guimeng; et al. (International Journal of Intelligent Systems, 2022)